New Key Statistics Module, Z-Score and F-Score
OTCPK:KHTRF Key Ratios
| Market Cap $ M | 437.40 |
| Enterprise Value $ M | 363.52 |
| P/E(ttm) | -- |
| PE Ratio without NRI | 49.66 |
| Forward PE Ratio | 98.04 |
| Price/Book | 0.80 |
| Price/Sales | 1.94 |
| Price/Free Cash Flow | 24.22 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 243.00 |
| EPS (TTM) $ | -0.12 |
| Beneish M-Score | -2.61 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 9.00 |
| y-y EBITDA Growth Rate % | 73.20 |
| EV-to-EBIT | -52.30 |
| EV-to-EBITDA | 12.15 |
| PEG | 5.52 |
| Shares Outstanding M | 101.17 |
| Net Margin (%) | -5.13 |
| Operating Margin % | 1.94 |
| Pre-tax Margin (%) | -6.70 |
| Quick Ratio | 2.40 |
| Current Ratio | 3.20 |
| ROA % (ttm) | -1.66 |
| ROE % (ttm) | -2.10 |
| ROIC % (ttm) | 0.66 |
| Dividend Yield % | -- |
| Altman Z-Score | 2.66 |
KHTRF Number of Guru Trades
KHTRF Volume of Guru Trades
Gurus Latest Trades with OTCPK:KHTRF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:KHTRF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Knight Therapeutics Inc Insider Transactions
No Available Data
News about OTCPK:KHTRF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers